Veracyte Inc (NASDAQ:VCYT) shares, rose in value on Wednesday, March 26, with the stock price down by -7.84% to the previous day’s close as strong demand from buyers drove the stock to $31.05.
Actively observing the price movement in the last trading, the stock closed the session at $33.69, falling within a range of $30.67 and $34.19. The value of beta (5-year monthly) was 1.801 whereas the PE ratio was 101.31 over 12-month period. Referring to stock’s 52-week performance, its high was $47.32, and the low was $18.61. On the whole, VCYT has fluctuated by -7.20% over the past month.
With the market capitalization of Veracyte Inc currently standing at about $2.42 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-23.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 488.01M, with a low estimate of 104M and a high estimate of 118.3M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 110.81M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VCYT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 2.35, with the price of VCYT currently trading nearly -3.56% and -18.28% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.04, while the 7-day volatility ratio is showing 5.49% which for the 30-day chart, stands at 5.67%. Furthermore, Veracyte Inc (VCYT)’s beta value is 2.01, and its average true range (ATR) is 1.89.
A comparison of Veracyte Inc (VCYT) with its peers suggests the former has fared considerably weaker in the market. VCYT showed an intraday change of -7.84% in last session, and over the past year, it grew by 47.23%%.
Data on historical trading for Veracyte Inc (NASDAQ:VCYT) indicates that the trading volumes over the past 10 days have averaged 0.83 and over the past 3 months, they’ve averaged 897.72K. According to company’s latest data on outstanding shares, there are 77.77 million shares outstanding.
Nearly 1.42% of Veracyte Inc’s shares belong to company insiders and institutional investors own 102.76% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.3 million shares as on 2025-03-14, resulting in a short ratio of 2.88. According to the data, the short interest in Veracyte Inc (VCYT) stood at 472.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.13 million. The stock has fallen by -21.59% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VCYT stock heading into the next quarter.
